首页> 外文期刊>藥學雜誌 >Adverse Event Trends Associated with Over-the-counter Combination Cold Remedy: Data Mining of the Japanese Adverse Drug Event Report Database
【24h】

Adverse Event Trends Associated with Over-the-counter Combination Cold Remedy: Data Mining of the Japanese Adverse Drug Event Report Database

机译:与反击结合相关的寒冷补救措施的不良事件趋势:日本不利药物事件报告数据库的数据挖掘

获取原文
获取原文并翻译 | 示例
           

摘要

OTC combination cold remedies are widely used in Japan. In the present study, we aimed to evaluate the adverse event profiles of OTC combination cold remedy based on the components using the Japanese Adverse Drug Event Report (JADER) database. The JADER database contained 430587 reports between April 2004 and November 2016. 1084 adverse events associated with the use of OTC combination cold remedy were reported. Reporting odds ratio (ROR) was used to detect safety signals. The ROR values for "skin and subcutaneous tissue disorders", "hepatobiliary disorders", and "immune system disorders" stratified by system organ class of the Medical Dictionary for Regulatory Activities (MedDRA) were 9.82 (8.71-11.06), 2.63 (2.25-3.07), and 3.13 (2.63-3.74), respectively. OTC combination cold remedy containing acetaminophen exhibited a significantly higher reporting ratio for "hepatobiliary disorders" than OTC combination cold remedy without acetaminophen. We demonstrated the potential risk of OTC combination cold remedy in a real-life setting. Our results suggested that the monitoring of individuals using OTC combination cold remedy is important.
机译:OTC组合冷疗得到广泛应用于日本。在本研究中,我们的目标是根据使用日本不利药物事件报告(JADER)数据库的组件来评估OTC组合冷补救措施的不良事件谱。 Jader数据库于2004年4月和2016年11月期间载有430587个报告。报告了与使用OTC组合冷疗有关的不良事件。报告赔率比(ROR)用于检测安全信号。由医学词典的系统器官类(MedDRA)的系统器官类(Meddra)分层的“皮肤和皮下组织疾病”,“肝胆疾病”和“免疫系统障碍”的ROR值为9.82(8.71-11.06),2.63(2.25- 3.07)和3.13(2.63-3.74)。含有对乙酰氨基酚的OTC组合冷补救液表现出比OTC组合冷疗法的“肝胆疾病”的报告比显着提高,没有乙酰氨基酚。我们展示了在现实生活中的OTC组合冷补救措施的潜在风险。我们的研究结果表明,使用OTC组合冷救济性的个体监测很重要。

著录项

  • 来源
    《藥學雜誌》 |2018年第1期|共12页
  • 作者单位

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Community Pharm 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Kizawa Mem Hosp 590 Kobicho Shimokobi Minokamo Gifu 5058503 Japan;

    Gifu Pharmaceut Univ Lab Community Pharm 1-25-4 Daigakunishi Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Drug Informat 1-25-4 Daigakunishi Gifu 5011196 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 jpn
  • 中图分类 药学;
  • 关键词

    OTC drug; combination cold remedy; adverse event; Japanese Adverse Drug Event Report database;

    机译:OTC药物;组合冷疗;不良事件;日本不良药物事件报告数据库;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号